Get started
Live feed
·
ANALYSTRatingvia Quantisnow
Alkermes plc logo

Alkermes Plc downgraded by BofA Securities with a new price target

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Historical context for ALKS

Across the 26 sessions after earlier ALKS headlines, the stock closed higher 19 times and lower 7 times, with a median move of 1.9% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

ALKS close-to-close change in the session after earlier headlines
SessionEarlier headlineALKSSPY
Jun 18, 2026Alkermes Presents Detailed Positive Results From Vibrance-2 Phase 2 Study of Alixorexton in Adults With Narcolepsy Type 2 at SLEEP 2026+1.1%+0.8%
Jun 15, 2026Alkermes Announces Orphan Drug Designations for Alixorexton in the U.S. and Europe+0.2%+1.8%
Jun 4, 2026Alkermes to Present New Data on Alixorexton and LUMRYZ® (sodium oxybate) at SLEEP 2026, Highlighting Breadth of Sleep Medicine Researchand 1 other headline that session+1.4%+0.4%
May 26, 2026Alkermes to Showcase Leadership in Psychiatry and Orexin Biology With New Data at the American Society of Clinical Psychopharmacology Annual Meeting+1.5%+0.7%
May 21, 2026Alkermes Showcases Data From Psychiatry Portfolio and Sleep Research into Real World Patient Experience at Spring 2026 Scientific Conferences-0.1%+0.2%
May 12, 2026Alkermes Announces Positive Topline Results From REVITALYZ℠ Phase 3 Study Evaluating LUMRYZ® (sodium oxybate) Extended-Release in Adults With Idiopathic Hypersomnia+8.0%-0.2%
Quantisnow market dataNASDAQ
Alkermes plc logo
ALKS
Alkermes plc
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
1991
Get push alerts for ALKS

Follow ALKS and get a push notification the moment its next story breaks.

Full ALKS profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ALKS (Alkermes plc) and more on Quantisnow.